Bordetella pertussis lipid a glucosamine modification confers resistance to cationic antimicrobial peptides and increases resistance to outer membrane perturbation

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 8, 2014, Pages 4931-4934

  Shah, Nita R ^a   Hancock, Robert E W ^a   Fernandez, Rachel C ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; ANTIMICROBIAL CATIONIC PEPTIDE; GLUCOSAMINE; LIPID A; POLYMYXIN;

AMINO ACID SEQUENCE; ANTIBIOTIC RESISTANCE; BORDETELLA PERTUSSIS; CELL MEMBRANE; CHEMISTRY; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MICROBIAL SENSITIVITY TEST; MOLECULAR GENETICS;

AMINO ACID SEQUENCE; ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BORDETELLA PERTUSSIS; CELL MEMBRANE; DRUG RESISTANCE, BACTERIAL; GLUCOSAMINE; LIPID A; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; POLYMYXINS;

EID: 84905400756     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02590-14     Document Type: Article

References (13)

1. Laube DM, Yim S, Ryan LK, Kisich KO, Diamond G. 2006. Antimicrobial peptides in the airway. Curr. Top. Microbiol. Immunol. 306:153-182. http://dx.doi.org/10.1007/3-540-29916-5-6.
2. de Gouw D, Diavatopoulos DA, Bootsma HJ, Hermans PW, Mooi FR. 2011. Pertussis: a matter of immune modulation. FEMS Microbiol. Rev. 35:441-474. http://dx.doi.org/10.1111/j.1574-6976.2010.00257.x.
3. Shah NR, Albitar-Nehme S, Kim E, Marr N, Novikov A, Caroff M, Fernandez RC. 2013. Minor modifications to the phosphate groups and the C3= acyl chain length of lipid A in two Bordetella pertussis strains, BP338 and 18-323, independently affect Toll-like receptor 4 protein activation. J. Biol. Chem. 288:11751-11760. http://dx.doi.org/10.1074/jbc.M112.434365.
4. Marr N, Hajjar AM, Shah NR, Novikov A, Yam CS, Caroff M, Fernandez RC. 2010. Substitution of the Bordetella pertussis lipid A phosphate groups with glucosamine is required for robust NF-kappaB activation and release of proinflammatory cytokines in cells expressing human but not murine Toll-like receptor 4-MD-2-CD14. Infect. Immun. 78:2060-2069. http://dx.doi.org/10.1128/ IAI.01346-09.
5. Wiegand I, Hilpert K, Hancock RE. 2008. Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat. Protoc. 3:163-175. http://dx.doi.org/10.1038/nprot.2007.521.
6. Marr N, Tirsoaga A, Blanot D, Fernandez R, Caroff M. 2008. Glucosamine found as a substituent of both phosphate groups in Bordetella lipid A backbones: role of a BvgAS-activated ArnT ortholog. J. Bacteriol. 190:4281-4290. http://dx.doi.org/10.1128/JB.01875-07.
7. Fernandez RC, Weiss AA. 1996. Susceptibilities of Bordetella pertussis strains to antimicrobial peptides. Antimicrob. Agents Chemother. 40:1041-1043.
8. Elahi S, Buchanan RM, Attah-Poku S, Townsend HG, Babiuk LA, Gerdts V. 2006. The host defense peptide beta-defensin 1 confers protection against Bordetella pertussis in newborn piglets. Infect. Immun. 74:2338-2352. http://dx.doi.org/10.1128/IAI.74.4.2338-2352.2006.
9. Taneja NK, Ganguly T, Bakaletz LO, Nelson KJ, Dubey P, Poole LB, Deora R. 2013. D-Alanine modification of a protease-susceptible outer membrane component by the Bordetella pertussis dra locus promotes resistance to antimicrobial peptides and polymorphonuclear leukocyte-mediated killing. J. Bacteriol. 195:5102-5111. http://dx.doi.org/10.1128/JB.00510-13.
10. Gellatly SL, Needham B, Madera L, Trent MS, Hancock RE. 2012. The Pseudomonas aeruginosa PhoP-PhoQ two-component regulatory system is induced upon interaction with epithelial cells and controls cytotoxicity and inflammation. Infect. Immun. 80:3122-3131. http://dx.doi.org/10.1128/IAI.00382-12.
11. Rolin O, Muse SJ, Safi C, Elahi S, Gerdts V, Hittle LE, Ernst RK, Harvill ET, Preston A. 2014. Enzymatic modification of lipid A by ArnT protects Bordetella bronchiseptica against cationic peptides and is required for transmission. Infect. Immun. 82:491-499. http://dx.doi.org/10.1128/IAI.01260-12.
12. Banemann A, Deppisch H, Gross R. 1998. The lipopolysaccharide of Bordetella bronchiseptica acts as a protective shield against antimicrobial peptides. Infect. Immun. 66:5607-5612.
13. Needham BD, Trent MS. 2013. Fortifying the barrier: the impact of lipid A remodelling on bacterial pathogenesis. Nat. Rev. Microbiol. 11:467-481. http://dx.doi.org/10.1038/nrmicro3047.